A detailed history of Sg Americas Securities, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 10,376 shares of MCRB stock, worth $7,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,376
Previous 52,080 80.08%
Holding current value
$7,470
Previous $73,000 89.04%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$0.75 - $1.56 $31,278 - $65,058
-41,704 Reduced 80.08%
10,376 $8,000
Q4 2023

Jan 12, 2024

BUY
$0.93 - $2.15 $48,434 - $111,972
52,080 New
52,080 $73,000
Q1 2023

Apr 28, 2023

BUY
$4.95 - $6.09 $145,713 - $179,271
29,437 Added 206.62%
43,684 $248,000
Q4 2022

Feb 02, 2023

SELL
$5.09 - $9.05 $8,495 - $15,104
-1,669 Reduced 10.49%
14,247 $80,000
Q3 2022

Oct 31, 2022

BUY
$3.5 - $7.2 $55,706 - $114,595
15,916 New
15,916 $102,000
Q1 2022

Apr 29, 2022

SELL
$6.3 - $8.84 $75,713 - $106,239
-12,018 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$6.02 - $11.43 $3.12 Million - $5.92 Million
-517,917 Reduced 97.73%
12,018 $100,000
Q3 2021

Nov 01, 2021

BUY
$5.46 - $22.6 $2.81 Million - $11.6 Million
514,675 Added 3372.71%
529,935 $3.69 Million
Q2 2021

Aug 12, 2021

SELL
$18.46 - $24.36 $29,517 - $38,951
-1,599 Reduced 9.48%
15,260 $364,000
Q1 2021

May 13, 2021

SELL
$17.66 - $28.92 $35,779 - $58,591
-2,026 Reduced 10.73%
16,859 $347,000
Q4 2020

Feb 04, 2021

BUY
$23.25 - $37.73 $439,076 - $712,531
18,885 New
18,885 $463,000
Q3 2020

Nov 09, 2020

SELL
$3.74 - $28.74 $105,423 - $810,123
-28,188 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$3.04 - $6.2 $85,691 - $174,765
28,188 New
28,188 $134,000
Q3 2019

Nov 04, 2019

SELL
$2.29 - $4.16 $24,097 - $43,775
-10,523 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$2.28 - $7.35 $23,992 - $77,344
10,523 New
10,523 $34,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.